Phenolic polymers are prepared by oxidizing and polymerizing starting organic compounds comprising at least one hydroxyl group and at least one carbonyl group or at least two hydroxyl groups on an aromatic structure. One or more inorganic compounds or salts is added and the solution is allowed to stand at about 20.degree. C. to 80.degree. C. for a period of about at least 2 hours. Salt molecules as well as starting compounds and other low molecular-weight materials below about 500 to about 10,000 daltons are removed from the product solution. Purified phenolic polymers are prepared in concentrated aqueous solution or in dried powder form in a final step if necessary. The resultant phenolic polymers exhibit physicochemical properties strongly resembling those of typical commercially-available natural-product soil extracts. The materials are active hemorrhagic fever anti-viral agents, and are effective in anti-viral compositions for treating or preventing hemorrhagic fever viral diseases.

Laub Biochemicals Corp.

Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon

A blending of a styrenic resin, and a flame retardant comprising a phenolic resin and a phosphazene compound to a polyalkylene arylate-series resin imparts flame retardancy to a polyalkylene arylate-series resin. The phosphazene compound is a cyclic phenoxyphosphazene compound, a linear phenoxyphosphazene compound, or a crosslinked phenoxyphosphazene compound. The obtained polyalkylene arylate-series resin composition has excellent heat resistance and high flame-retardancy without bleeding out the flame retardant.

Polyplastics Co., Ltd.

Flame-retardant resin composition

The invention relates to novel compositions comprising of an extract of the plant Euphorbia prostrata, particularly with pharmaceutically acceptable carrier(s)/base(s), optionally with additional therapeutic agent(s) useful for the treatment of anorectal disease and colonic diseases such as hemorrhoids, fissures, cracks, fistulas, abscesses, inflammatory bowel disease, and the like. The novel compositions possess properties to control inflammation, prevent capillary bleeding and fragility in mammalians, particularly human beings. Process for the preparation of such novel compositions comprising an extract of the plant Euphorbia prostrata and pharmaceutically acceptable carrier(s)/base(s) useful for the treatment of anorectal disease including hemorrhoids, and colonic diseases are also provided. The composition comprise of flavonoidal and phenolic constituents extracted from the plant Euphorbia prostrata that possess anti-inflammatory, analgesic, haemostatic and wound-healing properties.

phenolic/krvarenje

Synthetic soil-extract materials and medicaments for hemorrhagic fever viruses based thereon

Flame-retardant resin composition

Pharmaceutical compositions comprising an extract of Euphorbia prostrata

Najkompletnija baza ljekovitog bilja potpomognuta naukom